FrancophonIA/ELRC3.0 huggingface dataset:
English: Rare: may affect up to 1 in 1,000 people - infection - decreased number of all blood cell types - severe allergic reactions (DRESS, anaphylactic reaction [severe and important allergic reaction], Quincke's oedema [swelling of the face, lips, tongue and throat])) - decreased blood sodium concentration - suicide, personality disorders (behavioural problems), thinking abnormal (slow thinking, unable to concentrate) - delirium - encephalopathy (see sub-section “Tell your doctor immediately” for a detailed description of symptoms) - uncontrollable muscle spasms affecting the head, torso and limbs, difficulty in controlling movements, hyperkinesia (hyperactivity) - pancreatitis - liver failure, hepatitis - sudden decrease in kidney function - skin rash, which may form blisters and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme), a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (StevensJohnson syndrome), and a more severe form causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis) rhabdomyolysis (breakdown of muscle tissue) and associated blood creatine phosphokinase increase.
Danish: Sjælden: kan påvirke op til 1 ud af 1.000 - infektion; - nedsat antal af alle typer blodlegemer; alvorlige allergiske reaktioner (DRESS, anafylaktisk reaktion (alvorlig og vigtig allergisk reaktion), Quinckes ødem (hævelse af ansigt, læber, tunge og svælg)); - nedsat natriumindhold i blodet; - selvmord, personlighedsforstyrrelser (adfærdsproblemer), unormal tankevirksomhed (langsom tankegang, koncentrationsbesvær); - delirium (uklarhed, forvirring og desorientering); - encefalopati (se underafsnittet ”KontaktFortæl omgående lægen” for en detaljeret beskrivelse af symptomer); - ukontrollerede muskelspasmer med indvirkning på hovedet, kroppen samt arme og ben; vanskelighed med at kontrollere kroppens bevægelser, ufrivillige bevægelser; - betændelse i bugspytkirtlen; - leversvigt, leverbetændelse; - pludseligt nedsat nyrefunktion; - hududslæt, der kan danne blærer, og som ligner små skydeskiver (mørk plet i midten omgivet af et blegere område, med en mørk ring om kanten) (erythema multiforme), et udbredt udslæt med blærer og skællende hud, især omkring munden, næsen, øjnene og kønsdelene (StevensJohnson syndrom) og en mere alvorlig form, der forårsager afskalning af hud på mere end 30 % af kropsoverfladen (toksisk epidermal nekrolyse);
English: The NOAEL (No Observed Adverse Effect Level) was 3600 mg/kg/day for pregnant female rats (x 12 the MRHD on a mg/m2 basis) and 1200 mg/kg/day for fetuses.
Danish: NOAEL (No Observed Adverse Effect Level) var 3.600 mg/kg/dag for drægtige hunrotter (12 x MRHD (Maximum Recommended Human Dose) på basis af mg/m2) og 1.200 mg/kg/dag for fostre.
English: Hypersensitivity to the active substance or other pyrrolidone derivatives or to any of the excipients listed in section 6.1.
Danish: Overfølsomhed over for det aktive stof eller andre pyrrolidonderivater eller over for et eller flere af hjælpestofferne anført i punkt.
English: confusion, panic attack, emotional instability/mood swings, agitation - amnesia (loss of memory), memory impairment (forgetfulness), abnormal coordination/ataxia
Danish: forvirring, panikanfald, følelsesmæssig ustabilitet/humørsvingninger, rastløs uro; - amnesi (hukommelsestab), hukommelsessvækkelse (glemsomhed), koordinationsbesvær,
English: Four embryo-foetal development studies were performed in rabbits covering doses of 200, 600, 800, 1200 and 1800 mg/kg/day.
Danish: Der blev udført fire embryo-føtale udviklingsforsøg med doser på 200, 600, 800, 1.200 og 1.800 mg/kg/dag i kaniner.
English: Amnesia, memory impairment, coordination abnormal/ataxia, paraesthesia, disturbance in attention
Danish: Amnesi, hukommelsessvækkelse, koordinationsforstyrrelser/ ataksi, paræstesi, opmærksomhedsforstyrrel ser
English: undergoing dialysis (1) (1) A 750 mg loading dose is recommended on the first day of treatment with levetiracetam.
Danish: (1) En 750 mg støddosis anbefales på første behandlingsdag med levetiracetam.
English: Levetiracetam SUN concentrate for solution for infusion is packed in a cardboard box containing 10 vials of 5 ml.
Danish: Levetiracetam SUN-koncentrat til infusionsvæske, opløsning er pakket i en papæske, som indeholder 10 hætteglas a 5 ml.
English: Preparation and administration of Levetiracetam SUN concentrate
Danish: Tabe1 Fremstilling og administration af Levetiracetam SUN-koncentrat
English: Two embryo-foetal development (EFD) studies were performed in rats at 400, 1200 and 3600 mg/kg/day.
Danish: Der blev udført to embryo-føtale udviklingsforsøg med 400, 1.200 og 3.600 mg/kg/dag i rotter.
English: 500 to 1,000 mg once daily (2)
Danish: 500 til 1.000 mg en gang dagligt (2)
English: See Table 1 for the recommended preparation and administration of Levetiracetam SUN concentrate to achieve a total daily dose of 500 mg, 1000 mg, 2000 mg, or 3000 mg in two divided doses.
Danish: Se Tabel 1 for den anbefalede fremstilling og administration af Levetiracetam SUNkoncentrat for at opnå en samlet daglig dosis på 500 mg, 1.000 mg, 2.000 mg eller 3.000 mg fordelt på to doser.
English: - If you have any further questions, ask your doctor or nurse.
Danish: - Spørg lægen eller sygeplejersken, hvis der er mere, De vil vide.
English: Levetiracetam SUN concentrate was found to be physically compatible and chemically stable when mixed with the following diluents for at least 24 hours and stored in PVC bags at controlled room temperature 15-25°C.
Danish: Levetiracetam SUN-koncentrat er fundet fysisk kompatibelt og kemisk stabilt i mindst 24 timer, når det fortyndes med følgende injektionsvæsker og opbevares i PVC beholdere ved kontrolleret stuetemperatur på 15-25 °C.
English: Very common: may affect more than 1 in 10 people - nasopharyngitis - somnolence (sleepiness), headache
Danish: Meget almindelig: kan påvirke flere end 1 ud af 10 - snue; - døsighed, hovedpine.
English: See Table 1 for the recommended preparation and administration of Levetiracetam SUN concentrate for solution for infusion to achieve a total daily dose of 500 mg, 1000 mg, 2000 mg, or 3000 mg in two divided doses.
Danish: Se Tabel 1 for den anbefalede klargøring og administration af Levetiracetam SUN-koncentrat til infusionsvæske, opløsning, for at opnå en samlet daglig dosis på 500 mg, 1.000 mg, 2.000 mg eller 3.000 mg fordelt på to doser.
English: Levetiracetam SUN concentrate for solution for infusion can be used when administration of oral levetiracetam is temporarily impossible.
Danish: Levetiracetam SUN-koncentrat til infusionsvæske, opløsning kan anvendes, når det midlertidigt ikke er muligt at give levetiracetam gennem munden.
English: - The other ingredients are: sodium acetate trihydrate, glacial acetic acid, sodium chloride, water for injection.
Danish: - Øvrige indholdsstoffer: natriumacetattrihydrat, iseddikesyre, natriumchlorid, vand til injektionsvæsker.
English: Other ingredients include sodium acetate trihydrate, glacial acetic acid, sodium chloride, water for injection.
Danish: Andre indholdsstoffer er natriumacetattrihydrat, iseddikesyre, natriumchlorid, vand til injektionsvæsker.
English: Levetiracetam SUN concentrate for solution for infusion was found to be physically compatible and chemically stable when mixed with the following diluents for at least 24 hours and stored in PVC bags at controlled room temperature 15-25°C.
Danish: Levetiracetam SUN-koncentrat til infusionsvæske, opløsning er fundet fysisk kompatibelt og kemisk stabilt i mindst 24 timer, når det blandes med følgende fortyndere og opbevares i PVC beholdere ved kontrolleret stuetemperatur på 15-25 °C.
English: Alopecia, eczema, Toxic epidermal
Danish: Alopeci, eksem, pruritus Toksisk epidermal nekrolyse, Stevens
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 14 December 2011
Danish: DATO FOR FØRSTE MARKEDSFØRINGSTILLADELSE/FORNYELSE AF TILLADELSEN
English: What Levetiracetam SUN looks like and contents of the pack Levetiracetam SUN concentrate for solution for infusion (sterile concentrate) is a clear, colourless liquid.
Danish: Levetiracetam SUN-koncentrat til infusionsvæske, opløsning (sterilt koncentrat) er en klar, farveløs væske.
English: Dose in children (4 to 11 years) and adolescents (12 to 17 years) weighing less than 50 kg General dose: between 20 mg per kg bodyweight and 60 mg per kg bodyweight each day.
Danish: Dosis til børn og unge (4 til 17 år), som vejer under 50 kg Den sædvanlige dosis er mellem 20 mg og 60 mg pr. kg legemsvægt dagligt.
English: Creatinine clearance Dose and frequency (ml/min/1.73 m2)
Danish: Nyrefunktion Kreatininclearance (ml/min/1,73 m2)
English: lethargy (lack of energy and enthusiasm), tremor (involuntary trembling) - vertigo (sensation of rotation) - cough - abdominal pain, diarrhoea, dyspepsia (indigestion), vomiting, nausea - rash - asthenia/fatigue (tiredness)
Danish: (mangel på energi og entusiasme), tremor (ufrivillig rysten); - vertigo (følelse af at snurre rundt); - hoste; - mavesmerter, diarré, dyspepsi (fordøjelsesbesvær), opkastning, kvalme; - udslæt; - kraftesløshed og svaghed/træthed.
English: One maximum single dose of Levetiracetam SUN concentrate contains 2.5 mmol (or 57 mg) of sodium (0.8 mmol (or 19 mg) of sodium per vial).
Danish: Levetiracetam SUN-koncentrat indeholder 2,5 mmol (eller 57 mg) natrium (0,8 mmol (eller 19 mg) natrium pr. hætteglas) pr. maksimal enkeltdosis.
English: In this study, levetiracetam, dose was 3000 mg/day given in 2 divided doses.
Danish: I dette studie var levetiracetam-dosis 3.000 mg/dag fordelt på 2 doser.
English: Neonatal and juvenile animal studies in rats and dogs demonstrated that there were no adverse effects seen in any of the standard developmental or maturation endpoints at doses up to 1800 mg/kg/day (x 6-17 the MRHD on a mg/m2 basis).
Danish: Neonatale og juvenile dyrestudier med rotter og hunde demonstrerede, at der med doser op til 1.800 mg/kg/dag (6-17 x MRHD på basis af mg/m2) ikke var uønskede virkninger på standardudvikling og modningsmålepunkter.
English: The daily dose must be individualised according to renal function.
Danish: Nedsat nyrefunktion Den daglige dosis skal justeres individuelt i forhold til nyrefunktion.
English: Levetiracetam SUN is indicated as adjunctive therapy - in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy - in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy - in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
Danish: Levetiracetam SUN er indiceret som tillægsbehandling - af voksne, unge og børn over 4 år med partiel epilepsi med eller uden sekundær generalisering - af voksne og unge over 12 år med juvenil myoklon epilepsi med myoklone anfald - af voksne og unge over 12 år med idiopatisk generaliseret epilepsi med primært generaliserede tonisk-kloniske anfald
English: Diluents: - Sodium chloride 9 mg/ml (0.9%) solution for injection - Lactated Ringer's solution for injection - Dextrose 50 mg/ml (5%) solution for injection
Danish: Fortyndere: - Natriumchlorid 9 mg/ml (0,9 %) injektionsvæske, opløsning - Ringer lactat injektionsvæske, opløsning - Glucose 50 mg/ml (5 %) injektionsvæske, opløsning
English: STATEMENT OF ACTIVE SUBSTANCE(S) One vial contains 500 mg/5 ml levetiracetam.
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Et hætteglas indeholder 500 mg/5 ml levetiracetam.
English: Serum Creatinine (mg/dl) ks= 0.55 in Children to less than 13 years and in adolescent female; ks= 0.7 in adolescent male Dosing adjustment for children and adolescents patients weighing less than 50 kg with impaired renal function
Danish: ks= 0,55 hos børn under 13 år og hos unge kvinder; ks= 0,7 hos unge drenge.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Levetiracetam SUN 100 mg/ml sterile concentrate levetiracetam
Danish: LÆGEMIDLETS NAVN OG ADMINISTRATIONSVEJ(E) Levetiracetam SUN 100 mg/ml koncentrat, sterilt levetiracetam i.v.
English: 250 mg 2.5 ml (half 5 ml vial)
Danish: 250 mg 2,5 ml (halvdelen af et 5 ml hætteglas)
English: Starting dose: 10 mg/kg twice daily
Danish: Initial dosis: 10 mg/kg to gange dagligt
English: Adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
Danish: Tillægsbehandling af voksne og unge over 12 år med juvenil myoklon epilepsi med myoklone anfald.
English: Adjunctive therapy in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
Danish: Tillægsbehandling af voksne og unge fra 12 år med idiopatisk generaliseret epilepsi med primært generaliserede tonisk-kloniske anfald.
English: 10 to 20 mg/kg (0.10 to 0.20 ml/kg) once daily (1) (2)
Danish: 10 til 20 mg/kg (0,10 til 0,20 ml/kg) en gang dagligt (1) (2)
English: Children from 4 years and adolescents weighing less than 50 kg
Danish: Dosis og hyppighed Børn over 4 år og unge som vejer under 50 kg
English: A double-blind, placebo-controlled paediatric safety study with a non-inferiority design has assessed the cognitive and neuropsychological effects of levetiracetam in children 4 to 16 years of age with partial onset seizures.
Danish: Leviteracetams kognitive og neuropsykologiske effekter hos børn i alderen 4-16 år med partielle anfald blev vurderet i et dobbeltblindt, placebokontrolleret pædiatrisk sikkerhedsstudie med noninferiort design.
English: Muscular weakness, myalgia
Danish: Muskelsvækkelse, myalgi Rabdomyolyse og
English: Preparation and administration of Levetiracetam SUN concentrate for solution for infusion
Danish: Klargøring og administration af Levetiracetam SUN-koncentrat til infusionsvæske, opløsning
English: Choreoathetosis, dyskinesia, hyperkinesia, gait disturbance.
Danish: Koreoatetose, dyskinesi, hyperkinesi, gangforstyrrelse, encefalopati
English: Levetiracetam has been given to you by your doctor to reduce the number of fits - with other antiepileptic medicines (add-on therapy) to treat: partial onset seizures with or without generalisation in adults, adolescents and children from 4 years of age myoclonic seizures (short, shock-like jerks of a muscle or group of muscles) in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy primary generalised tonic-clonic seizures (major fits, including loss of consciousness) in adults and adolescents from 12 years of age with idiopathic generalised epilepsy (the type of epilepsy that is thought to have a genetic cause).
Danish: - sammen med andre lægemidler (tillægsbehandling) mod epilepsi til behandling af: partielle anfald med eller uden generalisering hos voksne, unge og børn, der er over 4 år gamle myoklone anfald (korte, chok-lignende ryk i en muskel eller i en gruppe af muskler) hos voksne og unge over 12 år med juvenil myoklon epilepsi primært generaliserede tonisk-kloniske anfald (større anfald inklusiv bevidstløshed) hos voksne og unge over 12 år med idiopatisk generaliseret epilepsi (den type epilepsi, som menes at være genetisk forårsaget).
English: Deutschland Sun Pharmaceuticals Germany GmbH
Danish: Sun Pharmaceuticals Germany GmbH Hemmelrather Weg 201
English: 1000 mg 10 ml (two 5 ml vials)
Danish: 1.000 mg 10 ml (to 5 ml hætteglas)
English: Each 5 ml vial contains 500 mg of levetiracetam.
Danish: Hvert hætteglas på 5 ml indeholder 500 mg levetiracetam.
English: Package Leaflet: Information for the patient Levetiracetam SUN 100 mg/ml concentrate for solution for infusion levetiracetam
Danish: Indlægsseddel: Information til patienten Levetiracetam SUN 100 mg/ml koncentrat til infusionsvæske, opløsning levetiracetam
English: Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.
Danish: Monoterapi behandling af patienter over 16 år med nyligt diagnosticeret partiel epilepsi med eller uden sekundær generalisering.
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
Danish: - Kontakt lægen eller apotekspersonalet, hvis De får bivirkninger, herunder bivirkninger, som ikke er nævnt her.
English: Medicinal product with particulate matter or discoloration should not be used.
Danish: Præparater med uklarhed og misfarvning må ikke anvendes.
English: (impaired coordinated movements), paraesthesia (tingling), disturbance in attention (loss of concentration) - diplopia (double vision), vision blurred - elevated/abnormal values in a liver function test - hair loss, eczema, pruritus - muscle weakness, myalgia (muscle pain) - injury
Danish: opmærksomhedsforstyrrelser (koncentrationsbesvær); - dobbeltsyn, sløret syn; - forhøjede/unormale værdier i leverfunktionsprøver; - hårtab, eksem, kløe; - muskelsvaghed, muskelsmerter; - skader ved uheld.
English: The safety and efficacy of Levetiracetam SUN in children below and adolescents 16 years as monotherapy treatment have not been established.
Danish: Levetiracetam SUN's sikkerhed og virkning som monoterapibehandling hos børn og unge under 16 år er ikke klarlagt.
English: The safety and efficacy of Levetiracetam SUN concentrate for solution for infusion in infants and children less than 4 years have not been established.
Danish: Tillægsbehandling til spædbørn og børn under 4 år Sikkerhed og virkning af Levetiracetam SUN-koncentrat til infusionsvæske, opløsning hos spædbørn og børn under 4 år er ikke fastslået.
English: Levetiracetam SUN is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Danish: Levetiracetam SUN er indiceret til monoterapibehandling af voksne og unge over 16 år, som for nyligt har fået stillet diagnosen partiel epilepsi med eller uden sekundær generalisering.
English: Rhabdomyolysis and blood creatine phosphokinase increased*
Danish: Sjælden og bindevæv forhøjet indhold af kreatinkinase i blodet*
English: How to store Levetiracetam SUN
Danish: Sådan får De Levetiracetam SUN
English: Frequency of administration
Danish: Administrationshyppighed
English: CLcr (ml/min) = -------------------------------------- (x 0.85 for women)
Danish: [140-alder (år)] x vægt (kg) CLcr (ml/min) = -----------------------------------------(x 0,85 for kvinder) 72 x serum-kreatinin (mg/dl)
English: The NOAEL was ≥ 1800 mg/kg/day for the F0 females, and for the survival, growth and development of the F1 offspring up to weaning.
Danish: NOAEL var ≥1.800 mg/kg/dag for F0-hunnerne samt for overlevelse, vækst og udvikling af F1-afkom indtil ophør af diegivning (6 x MRHD på basis af mg/m2).
English: 10 vials of concentrate for solution for infusion
Danish: 10 hætteglas med koncentrat til infusionsvæske, opløsning
English: Adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy:
Danish: Tillægsbehandling af voksne, unge og børn over 4 år med partiel epilepsi med eller uden sekundær generalisering.
English: 10 to 30 mg/kg (0.10 to 0.30 ml/kg) twice daily
Danish: 10 til 30 mg/kg (0,10 til 0,30 ml/kg) to gange dagligt
English: If you have any symptoms of depression and/or thoughts about committing suicide, please contact your doctor.
Danish: Kontakt Deres læge, hvis De har symptomer på depression og/eller selvmordstanker.
English: What Levetiracetam SUN contains - The active substance is called levetiracetam.
Danish: - Aktivt stof: levetiracetam.
English: NAME OF THE MEDICINAL PRODUCT Levetiracetam SUN 100 mg/ml concentrate for solution for infusion
Danish: LÆGEMIDLETS NAVN Levetiracetam SUN 100 mg/ml koncentrat til infusionsvæske, opløsning.
English: Levetiracetam SUN is not indicated in children and adolescents below 16 years on its own (monotherapy).
Danish: Børn og unge - Levetiracetam SUN, som eneste lægemiddel (monoterapi), er ikke indiceret til børn og unge under 16 år.
English: 1500 mg 15 ml (three 5 ml vials) 100 ml
Danish: 1.500 mg 15 ml (tre 5 ml hætteglas)
English: NAME OF THE MEDICINAL PRODUCT Levetiracetam SUN 100 mg/ml concentrate for solution for infusion levetiracetam
Danish: Levetiracetam SUN 100 mg/ml koncentrat til infusionsvæske, opløsning levetiracetam
English: limp or difficulty walking.
Danish: Lever og galdeveje
English: Sodium acetate trihydrate Glacial acetic acid Sodium chloride Water for injection
Danish: Natriumchlorid Vand til injektionsvæsker
English: Levetiracetam efficacy was established in a double-blind, placebo-controlled study of 16 weeks duration, in patients 12 years of age and older suffering from idiopathic generalized epilepsy with myoclonic seizures in different syndromes.
Danish: Levetiracetams virkning hos patienter over 12 år med idiopatisk generaliseret epilepsi med myoklone anfald i forskellige syndromer blev påvist i et dobbeltblindt, placebokontrolleret studie med en behandlingsvarighed på 16 uger.
English: 500 mg 5 ml (one 5 ml vial)
Danish: 500 mg 5 ml (et 5 ml hætteglas) 100 ml minutter
English: 15 minutes Twice daily 2000 mg/day
Danish: 2.000 mg/dag mg
English: Add-on therapy
Danish: Nasofaryng itis
English: How Levetiracetam SUN is given
Danish: Sådan få De Levetiracetam SUN Bivirkninger
English: If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Danish: Spørg lægen eller apotekspersonalet, hvis der er noget, De er i tvivl om.
English: This should be taken into consideration if you are on a controlled sodium diet.
Danish: Hvis De er på natrium- eller saltfattig diæt, skal De tage hensyn hertil.
English: Blood cell counts
Danish: Blodtælling
English: 15 minutes Twice daily 3000 mg/day
Danish: 15 minutter 2 gange dagligt
English: Food enhances the absorption.
Danish: Foder øger absorptionen.
English: ATCvet code: QP53BE04
Danish: ATCvet-kode: QP53BE04
English: Appropriate combination of tablets
Danish: Passende kombination af tabletter
English: Blisters (dogs)
Danish: Blister (hunde)
English: STATEMENT OF ACTIVE SUBSTANCES 12 mg lotilaner
Danish: ANGIVELSE AF AKTIVE STOFFER 12 mg lotilaner
English: These signs typically resolve without treatment.
Danish: Disse tegn forsvinder normalt af sig selv uden behandling.
English: The terminal half-life is approximately 4 weeks.
Danish: Den terminale halveringstid er ca. 4 uger.
English: During clinical testing, no interactions between Credelio chewable tablets and routinely used veterinary medicinal products were observed.
Danish: I forbindelse med kliniske test blev der ikke observeret interaktion mellem Credelio tyggetabletter og rutinemæssigt anvendte veterinærlægemidler.
English: Strength and number of tablets to be administered
Danish: Styrke og antal tabletter, der skal administreres
English: Strength and number of tablets to be administered Credelio 12 mg
Danish: Styrke og antal tabletter, der skal administreres Credelio 12 mg
English: Pharmacotherapeutic group: ectoparasiticides for systemic use, isoxazolines.
Danish: Farmakoterapeutisk gruppe: ectoparasiticider til systemisk brug, isoxazoliner.
English: Due to insufficient data to support efficacy against ticks in young cats, this product is not recommended for the treatment of ticks in kittens 5 months of age or younger.
Danish: Da der er utilstrækkelige data til at påvise effekt mod flåter hos unge katte, anbefales produktet ikke til behandling mod flåter hos killinger på 5 måneder eller yngre.